ArticleEuropean spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society2026
Perioperative management of antithrombotic therapy in elderly patients undergoing elective ACDF: implementation and outcomes of a standardized institutional protocol.
Article in European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
19 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivePerioperative management of chronic antithrombotic therapy in elderly patients undergoing elective anterior cervical discectomy and fusion (ACDF) remains poorly standardized. This study evaluated the safety and feasibility of an institutional protocol based on temporary substitution rather than interruption of preexisting antithrombotic regimens.
methodsWe retrospectively analyzed 189 consecutive patients aged ≥ 65 years who underwent elective ACDF between 2019 and 2023. Patients were stratified according to their chronic antithrombotic regimen. Group A included patients with no prior antithrombotic therapy, who received standard postoperative prophylaxis with enoxaparin after drain removal. Group B comprised patients on primary prevention therapy, whose home regimen was discontinued 7 days before surgery and replaced with bridging low-molecular-weight heparin (enoxaparin 40 mg daily) until 15 days postoperatively. Group C included patients on secondary prevention therapy, who suspended their regimen 7 days preoperatively and received low-dose aspirin (100 mg daily) from the preoperative week through postoperative day 15 before resuming their chronic therapy. Primary outcomes were hemoglobin decrease, operative time, and length of stay, while secondary outcomes included complications (Clavien-Dindo classification) and early functional recovery (mJOA, ODI). Non-inferiority analyses using the TOST procedure evaluated whether perioperative outcomes remained within predefined a priori clinical margins across groups.
resultsBaseline characteristics and surgical parameters were comparable among groups. No major hemorrhagic or thromboembolic events occurred. Perioperative parameters and minor complications (Clavien-Dindo I-II) were similar across all groups. Functional improvement at 3 months was consistent (p > 0.3).
conclusionThis substitution-based perioperative protocol proved feasible and clinically safe in elderly ACDF patients. Although underpowered to detect rare events, these findings support prospective studies aimed at further investigating the adoption of standardized replacement strategies in this growing surgical population.
Indexed as
Identifiers
42086792What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.